In-Hospital Economic Burden of Metastatic Renal Cell Carcinoma in France in the Era of Targeted Therapies: Analysis of the French National Hospital Database from 2008 to 2013

• Rana Maroun ,

  Contributed equally to this work with: Rana Maroun, Franck Maunoury, Laure Benjamin, Gaëlle Nachbaur, Isabelle Durand-Zaleski

  * E-mail: rana.r.maroun@gsk.com

  Affiliations GlaxoSmithKline, Marly le Roi, France, ECEVE, Inserm, Paris, France

  ⨯
• Franck Maunoury ,

  Contributed equally to this work with: Rana Maroun, Franck Maunoury, Laure Benjamin, Gaëlle Nachbaur, Isabelle Durand-Zaleski

  Affiliation Statesia, Le Mans, France

  ⨯
• Laure Benjamin ,

  Contributed equally to this work with: Rana Maroun, Franck Maunoury, Laure Benjamin, Gaëlle Nachbaur, Isabelle Durand-Zaleski

  Affiliation GlaxoSmithKline, Marly le Roi, France

  ⨯
• Gaëlle Nachbaur ,

  Contributed equally to this work with: Rana Maroun, Franck Maunoury, Laure Benjamin, Gaëlle Nachbaur, Isabelle Durand-Zaleski

  Affiliation GlaxoSmithKline, Marly le Roi, France

  ⨯
• Isabelle Durand-Zaleski

  Contributed equally to this work with: Rana Maroun, Franck Maunoury, Laure Benjamin, Gaëlle Nachbaur, Isabelle Durand-Zaleski

  Affiliations URC Eco Ile-de-France, AP-HP, Paris, France, ECEVE, Inserm, Paris, France

  ⨯